Before Surgery
- Treat anemia early
- IV iron to refill stores
- EPO to build red cells
- Bank your own blood (PAD)
Names & Terms You Will Hear
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| Blood conservation | Steps that lower how much donor (someone else's) blood you need. The goal is fewer transfusions, not zero care. |
| Patient blood management (PBM) | The full plan that combines many tools across your surgery. It treats your own blood as something to protect. |
| Cell saver (cell salvage) | A machine that collects blood you lose during surgery, washes it, and gives it back to you. |
| Autologous blood | Your own blood. The opposite of donor (allogeneic) blood, which comes from a volunteer. |
| Pre-operative autologous donation (PAD) | Banking your own blood in the weeks before surgery so it can be given back to you later. |
| Acute normovolemic hemodilution (ANH) | Removing some of your blood at the start of surgery, replacing the volume with fluid, then giving your blood back at the end. |
| Erythropoietin (EPO) | A medicine like the hormone your kidneys make. It tells your marrow to build more red blood cells. |
| Tranexamic acid (TXA) | A medicine that helps clots hold. It slows bleeding during and after surgery. |
| Volume expander | An IV fluid that keeps your blood pressure up when you lose blood. It carries no oxygen — it only fills the tank. |
| Blood substitute (HBOC) | A lab-made oxygen carrier meant to stand in for red cells. None are FDA-approved for routine use in the US (see the honest note inside). |
Two companion guides: If you wish to avoid donor blood entirely, see our Bloodless Medicine & Surgery guide. To understand what a transfusion is and when it is truly needed, see our Blood Transfusion guide. This guide sits between them: the tools that reduce the need for donor blood.
What Is Blood Conservation?
- Blood conservation is a set of tools that work together to lower how much donor blood you need for surgery. Many patients can avoid a transfusion entirely.
- It is built on three ideas: build up your own blood before surgery, save the blood you have during surgery, and help your body rebuild after.
- Some tools give you back your OWN blood (cell saver, banking, hemodilution). Some are medicines that reduce bleeding or build red cells (TXA, IV iron, EPO).
- These tools are useful for everyone, not only patients who decline blood for personal or religious reasons. Less donor blood means fewer transfusion risks for all.
- The timeline below shows where each tool fits. Most surgeries use several tools at once. That combined plan is called patient blood management.
The Toolkit at a Glance — When Each Tool Is Used
| Tool | When it is used | Your own blood? | Key point |
|---|---|---|---|
| Cell saver (salvage) | During surgery | Yes | Collects, washes, and returns blood you lose. |
| Bank your own (PAD) | Weeks before surgery | Yes | Your exact-match blood is set aside for you. |
| Hemodilution (ANH) | Start of surgery | Yes | Fresh blood removed, then given back at the end. |
| IV iron + EPO | Weeks before surgery | Yes (builds it) | Treats anemia so you start with a higher count. |
| Tranexamic acid (TXA) | During and after surgery | Helps keep it | Slows bleeding; cuts the need for blood products. |
| Volume expanders / HBOCs | During and after blood loss | No | Fluids fill the tank; HBOCs are not FDA-approved in the US. |
Why It Matters
- Donor blood is safe today, but it is not risk-free. It can cause reactions, fluid overload, and rare infections. Avoiding a transfusion you do not need removes those risks.
- Going into surgery with a low blood count (anemia) raises the chance you will need a transfusion. Treating anemia first, with time to spare, often prevents that.
- Your own blood is the best match for your body. Cell salvage and banking give it back to you with no donor-matching risk.
- Modern care gives blood only when it is truly needed (a 'restrictive' plan). Studies show this is as safe as giving it earlier, and it stretches the blood supply for those who need it most.
- The chart below shows how much each tool can cut the chance of needing donor blood. No single tool does it all — they add up.
The Three Phases of a Blood Conservation Plan
During Surgery
- Cell saver returns your blood
- Hemodilution (ANH)
- Tranexamic acid (TXA)
- Careful, warm surgery
After Surgery
- Iron to rebuild counts
- Fewer, smaller lab draws
- Watch for low counts
- Give blood only if needed
Risk Factors
Knowing your personal risks helps your care team take extra precautions.
| Risk Factor | Why It Increases Risk |
|---|---|
| Anemia before surgery | A low blood count leaves no reserve for surgical blood loss, so a transfusion is far more likely. This is the single biggest fixable risk. |
| Iron deficiency | Low iron starves the marrow of the building block for red cells. IV iron can fix it within weeks, raising your count before surgery. |
| Surgery with high expected blood loss | Big operations (heart, spine, major orthopedic, some cancer surgery) lose more blood, so the conservation toolkit matters most here. |
| Blood thinners or bleeding disorders | Medicines like warfarin or a clotting problem raise bleeding. Planning when to hold them, plus TXA, lowers the loss. |
| Kidney disease | Sick kidneys make less natural EPO, so red-cell counts run low. An EPO medicine and iron can help build the count back up. |
| Declining donor blood | Some patients decline transfusion for personal or religious reasons. For them, every conservation tool is planned in advance (see our Bloodless Medicine guide). |
Treatment Options
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
- BEFORE surgery: find and treat anemia early. IV iron refills iron stores in weeks. An EPO shot tells the marrow to make more red cells. You can also bank your own blood (PAD).
- DURING surgery: the cell saver collects and washes blood you lose and returns it to you. Tranexamic acid (TXA) slows bleeding. ANH sets aside fresh blood to give back at the end.
- AFTER surgery: iron and good nutrition help rebuild red cells. The team draws fewer and smaller lab samples. Blood is given only if your count truly needs it.
- Most plans combine several tools. Your surgeon and anesthesiologist choose the mix based on your surgery, your blood count, and your wishes.
- Tell your team early if you want to avoid donor blood. The most powerful tools (treating anemia, EPO, banking) need weeks of lead time to work.
- The detailed map below shows which tools belong to each phase of your care.
Cell Saver (Intra-operative Blood Salvage)
- What it is: a machine that suctions up the blood you lose during surgery, spins and washes it, and returns your own clean red cells to you.
- When it is used: mainly in surgery where blood loss above about 500 mL is expected, such as heart, spine, major orthopedic, and some trauma surgery.
- Why it helps: it gives back YOUR own blood, so there is no donor-matching risk and no donor exposure. It can cut the need for donor blood by roughly a quarter to a third.
- The limits: it is generally avoided when infection or cancer cells could be in the surgical field. It also needs enough blood loss to be worthwhile.
Bank Your Own Blood (Pre-operative Autologous Donation)
- What it is: you donate your own blood in the weeks before surgery. It is stored and can be given back to you if you need it.
- When it is used: for planned surgery with a real chance of needing blood, in patients healthy enough to donate ahead of time.
- The trade-off: donating can leave you anemic going into surgery, and banked blood can expire unused. For many patients, treating anemia with iron and EPO is now preferred.
- The benefit: if you do need blood, it is your own exact match, with no donor-matching risk.
Acute Normovolemic Hemodilution (ANH)
- What it is: right at the start of surgery, the team removes some of your blood and replaces the volume with IV fluid. Your blood is kept safe in the room.
- How it helps: during surgery you bleed thinner, more diluted blood, so you lose fewer red cells. At the end, your saved whole blood (rich in cells and clotting factors) is given back.
- When it is used: in surgery with expected high blood loss, in patients who can safely tolerate having their blood briefly diluted.
- Why patients like it: the blood never leaves the operating room and is returned the same day, fresh and fully your own.
IV Iron and Erythropoietin (EPO) — Build Your Count
- What they are: IV iron refills your body's iron stores. EPO is a medicine like the hormone your kidneys make; it tells your marrow to build more red cells.
- How fast they work: given a few weeks before surgery, they raise your blood count over about 2 to 4 weeks. This is why early planning matters so much.
- Who benefits most: patients with anemia or iron deficiency before surgery, and patients with kidney disease whose natural EPO is low.
- Safety note: EPO can slightly raise clot risk, so it is dosed carefully and always paired with enough iron. Your team weighs this for you.
Tranexamic Acid (TXA) — Slow the Bleeding
- What it is: a medicine that helps the clots you form hold together, so you bleed less. It is NOT a blood thinner.
- The evidence: in the ATACAS heart-surgery trial, TXA cut the share of patients needing blood products from 54.7% down to 37.9%, with no rise in clots or death.
- The caveat: at high doses it slightly raised seizures (0.7% vs 0.1%). Doses are adjusted, especially for kidney disease or a seizure history.
- Where it is used: heart, orthopedic, trauma, and many other surgeries. It is one of the most proven and widely used conservation tools.
Volume Expanders and Blood Substitutes (HBOCs)
- Volume expanders: these are IV fluids (such as saline or starches) that keep your blood pressure up after blood loss. They fill the tank but carry NO oxygen.
- Blood substitutes (HBOCs): lab-made oxygen carriers meant to stand in for red cells. They are still investigational.
- The honest US status: no HBOC is FDA-approved for routine use. One product is available only by special compassionate-use request, case by case.
- Bottom line: expanders are a proven first step after blood loss, but if your body truly needs oxygen-carrying capacity, donor red cells remain the standard.
The honest truth about 'blood substitutes': Lab-made oxygen carriers (HBOCs, hemoglobin-based oxygen carriers) are still investigational. None are FDA-approved for routine use in the US. One product is available only by special compassionate-use request, case by case. Volume expanders (IV fluids) keep your blood pressure up after blood loss, but they carry NO oxygen. If your body truly needs oxygen-carrying capacity, donor red cells remain the proven option. Do not plan your surgery around a substitute being available.
Comfort Measures at Home (No Medication Needed)
These simple steps support healing and ease symptoms. Use them alongside any medication your doctor prescribes.
- Eat iron-rich foods in the weeks before surgery: lean red meat, beans, lentils, spinach, and fortified cereals.
- Pair iron foods with vitamin C (citrus, peppers, strawberries) to help your gut absorb iron better.
- Limit coffee and tea right around iron meals — they block iron absorption. Space them an hour apart.
- Avoid alcohol and unneeded anti-inflammatory pills (like ibuprofen) before surgery, as your team advises — both can add to bleeding.
- Keep moving and stay well-hydrated as approved; good general health helps your marrow respond to iron and EPO.
- Bring a full medicine and supplement list. Some supplements (fish oil, high-dose vitamin E, ginkgo) can thin the blood.
Risks, Benefits, and Alternatives
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| Treat anemia before surgery (IV iron, EPO) | Iron infusion reactions (uncommon). EPO carries a small clot risk, so it is dosed carefully with iron. | Raises your blood count in 2 to 4 weeks. Lowers the chance you will need a transfusion. Best done with weeks of lead time. | Oral iron (slower). Accept a higher transfusion chance. Delay non-urgent surgery to allow treatment. |
| Cell saver (intra-operative salvage) | Not used when infection or cancer cells could be in the field. Needs enough blood loss to be worthwhile. | Gives back YOUR own washed blood. No donor match needed. Common in heart, spine, and major surgery. | Donor blood if salvage is not suitable. Other conservation tools (TXA, hemodilution). |
| Bank your own blood (PAD) | Can leave you anemic going into surgery. Blood can expire or go unused. Extra visits and cost. | Your exact-match blood is ready if needed. Removes donor-matching risk. | Treat anemia with iron/EPO instead (often preferred). Cell salvage. Donor blood. |
| Tranexamic acid (TXA) | Small rise in seizure risk at high doses (ATACAS). Used with care if you have had clots or seizures. | Cuts surgical bleeding and the need for blood products (54.7% down to 37.9% in ATACAS heart surgery). | No antifibrinolytic. Surgical control of bleeding alone. Cell salvage. |
| Volume expanders / blood substitutes (HBOCs) | Expanders carry no oxygen — they only fill the tank. HBOCs are not FDA-approved for routine US use and have safety concerns. | IV fluids keep blood pressure up after blood loss and buy time. They are a standard, proven first step. | Donor red cells when oxygen-carrying capacity is truly needed. Cell salvage and your own banked blood. |
Common Misconceptions
| Myth | Reality |
|---|---|
| Blood conservation means I will never get a transfusion. | Not true. Conservation lowers the chance you need donor blood, and many patients avoid it. But if your body truly needs blood to stay safe, you will still be offered it. The goal is the right amount, not zero. |
| These tools are only for people who refuse blood for religious reasons. | No. Avoiding a transfusion you do not need helps everyone. It removes transfusion risks and saves the donor supply for patients who truly need it. Conservation is now standard surgical care. |
| Blood given back by the cell saver is dirty or unsafe. | The cell saver washes your blood and removes debris before returning it. It is your own perfectly matched blood. It is widely used in heart and spine surgery. |
| There is a fake blood that can replace transfusions. | Blood substitutes (HBOCs) exist in research, but none are FDA-approved for routine use in the US. One product is available only by special compassionate-use request. Do not count on a substitute being available. |
| Iron pills work just as fast as an IV before surgery. | Oral iron is useful but slow and often poorly absorbed. When surgery is weeks away, IV iron raises your count faster and more reliably. Your team will choose based on your timeline. |
| If I bank my own blood, that is always the safest choice. | Banking can leave you anemic going INTO surgery, and the blood can expire unused. For many patients, treating anemia with iron and EPO is the better plan. Your team will advise. |
| Tranexamic acid is a blood thinner. | It is the opposite. TXA helps existing clots hold so you bleed less. It does not thin the blood. It is one of the most proven conservation tools. |
| Losing a little blood in surgery always means I need a transfusion. | Most people tolerate some blood loss well, especially with a good starting count. Modern care gives blood only when your count and symptoms truly call for it. |
Possible Complications
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Anemia going into surgery | If a low blood count is not treated in time, you start surgery with no reserve. This raises the chance of needing a transfusion. Treating it early is the fix. |
| Iron infusion reactions | IV iron is usually well tolerated. Mild reactions (flushing, aches) can occur; serious reactions are uncommon. The team watches you during the infusion. |
| Clot risk with EPO | EPO raises red-cell counts but can slightly raise clot risk. It is dosed carefully, paired with iron, and avoided or adjusted if you have had clots. |
| Limits of the cell saver | Salvage is not used when infection or cancer cells may be in the surgical field, or when blood loss is small. In those cases other tools are chosen. |
| Seizure risk with high-dose TXA | In heart surgery, high TXA doses slightly raised seizures (0.7% vs 0.1% in ATACAS). Dosing is adjusted, especially for kidney disease or seizure history. |
| Blood substitutes are not a safety net | HBOCs are not FDA-approved for routine US use and carry safety concerns. If you truly need oxygen-carrying capacity, donor red cells remain the proven option. |
Points to Know
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
- The safest unit of blood is often the one you never need. Conservation lowers your odds of a transfusion.
- Treating anemia BEFORE surgery is the single most powerful tool. It needs weeks of lead time.
- The cell saver gives back your OWN washed blood during surgery — no donor match required.
- Tranexamic acid (TXA) is proven to cut bleeding and transfusion (ATACAS). It is not a blood thinner.
- IV iron and EPO build your red-cell count in the weeks before surgery.
- No blood substitute (HBOC) is FDA-approved for routine use in the US. Do not rely on one.
- Tools work best COMBINED. Your team builds a personal plan called patient blood management.
- Tell your team early if you want to avoid donor blood, so the slow-acting tools have time to work.
When to Call Us — and When to Call 911
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
- Worsening tiredness, dizziness, or shortness of breath in the weeks before surgery — call us; you may be anemic and need treatment.
- A reaction during or after an iron infusion (rash, itching, trouble breathing) — tell the infusion team right away.
- New leg swelling, leg pain, or chest pain after starting EPO — call us; this can signal a clot.
- Bleeding that will not stop, or black/bloody stools, after surgery — call us today.
- Feeling faint, a racing heart, or chest pressure after surgery — call 911.
- Questions about avoiding donor blood for personal or religious reasons — call us BEFORE scheduling, so we can plan ahead.
- Confusion about which conservation tools are right for you — call us; we will walk through the plan.
Office: (727) 943-5200
Trusted Resources
Independent, evidence-based pages we recommend for deeper reading.
- Cleveland Clinic — Patient Blood Management — Plain-language overview of blood conservation tools, including salvage and pharmacologic alternatives.
- Mayo Clinic — Bloodless Medicine & Surgery — Patient guide to surgery that minimizes or avoids donor blood, and the tools that make it possible.
- AABB — Patient Blood Management — The transfusion-medicine society's patient resources on blood management and safe transfusion.
- Our Bloodless Medicine & Surgery guide — For patients who wish to avoid donor blood entirely — how a full bloodless plan is built.
- Our Blood Transfusion guide — What a transfusion is, when it is truly needed, and what to expect if you receive one.
Sources Used to Build This Guide
- Practice Guidelines for Perioperative Blood Management — ASA Task Force (Anesthesiology 2015;122:241-275) [guideline] — Master reference covering the full conservation toolkit — cell salvage, acute normovolemic hemodilution, preoperative autologous donation, antifibrinolytics, and multimodal algorithms. Structures the guide.
- Klein AA et al. — Association of Anaesthetists Guidelines: Cell Salvage for Peri-operative Blood Conservation 2018 (Anaesthesia 2018;73:1141-1150) [guideline] — Authoritative source on intra-operative cell salvage (the 'cell saver') — when it is used, its safety, and the >1000 mL blood-loss trigger. Anchors the cell-salvage section.
- Myles PS et al. — Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery (ATACAS, NEJM 2017;376:136-148) [clinical_trial] — Landmark RCT showing tranexamic acid cuts bleeding and transfusion in cardiac surgery (with the seizure caveat) — the evidence base for the antifibrinolytic section.
- Mueller MM et al. — Patient Blood Management: Recommendations of the 2018 Frankfurt Consensus Conference (JAMA 2019;321:983-997) [consensus_statement] — International consensus on the conservation/alternatives toolkit including IV iron and erythropoiesis-stimulating agents for preoperative anemia — supports the IV iron and EPO sections.
- Goodnough LT, Shander A — Patient Blood Management (Anesthesiology 2012;116:1367-1376) [review] — Foundational review defining the three pillars of PBM and the role of erythropoietin, iron, and blood-loss minimization — gives the guide its organizing framework.
- Munoz M et al. — Detection, Evaluation, and Management of Preoperative Anaemia: NATA Guidelines (Br J Anaesth 2011;106:13-22) [guideline] — NATA reference for diagnosing and correcting anemia before surgery with iron and ESAs — supports the 'optimize before surgery' framing and the IV-iron pathway.
- Carson JL et al. — Red Blood Cell Transfusion: 2023 AABB International Guidelines (JAMA 2023;330:1892-1902) [guideline] — Establishes the restrictive transfusion threshold that makes conservation strategies clinically meaningful — gives the 'why conserve' context.
- Cleveland Clinic — Blood Conservation / Bloodless Medicine (patient page) [patient_education] — Patient-facing model for explaining salvage, hemodilution, and pharmacologic alternatives in plain language; used to hold the guide at a 6th-grade reading level.
- FDA — Status of Hemoglobin-Based Oxygen Carriers (HBOCs) / Blood Substitutes (regulatory context) [regulatory_reference] — Source for the honest, current status of volume expanders and hemoglobin-based oxygen carriers — none are FDA-approved for routine US use — so the guide does not overstate 'blood substitute' availability.
